Second Primary Cancers: An Overview

Ries, 2007 2004, Cancer survivors: living longer, and now, better, Lancet, 364, 2153, 10.1016/S0140-6736(04)17601-0 Dores, 2005, Long-term cause-specific mortality among 41–146 one-year survivors of Hodgkin lymphoma (HL), Acta Oncologica, 23, 562S Travis, 2002, Therapy-associated solid tumors, Acta Oncol, 41, 323, 10.1080/028418602760169361 Travis, 2006, Cancer survivorship—genetic susceptibility and second primary cancers: research strategies and recommendations, J Natl Cancer Inst, 98, 15, 10.1093/jnci/djj001 van Leeuwen, 2005, Second cancers, 2575 Allan, 2005, Mechanisms of therapy-related carcinogenesis, Nat Rev Cancer, 5, 943, 10.1038/nrc1749 Arseneau, 1972, Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy, N Engl J Med, 287, 1119, 10.1056/NEJM197211302872204 Cimino, 1991, Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study, J Clin Oncol, 9, 432, 10.1200/JCO.1991.9.3.432 Henry-Amar, 1992, Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease, Ann Oncol, 3, 117, 10.1093/annonc/3.suppl_4.S117 Kaldor, 1990, Leukemia following Hodgkin's disease, N Engl J Med, 322, 7, 10.1056/NEJM199001043220102 Tucker, 1988, Risk of second cancers after treatment for Hodgkin's disease, N Engl J Med, 318, 76, 10.1056/NEJM198801143180203 Valagussa, 1986, Second acute leukemia and other malignancies following treatment for Hodgkin's disease, J Clin Oncol, 4, 830, 10.1200/JCO.1986.4.6.830 van Leeuwen, 1994, Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage, J Clin Oncol, 12, 1063, 10.1200/JCO.1994.12.5.1063 Andrieu, 1990, Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease, J Clin Oncol, 8, 1148, 10.1200/JCO.1990.8.7.1148 Ng, 2002, Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors, Blood, 100, 1989, 10.1182/blood-2002-02-0634 Diehl, 2003, Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease, N Engl J Med, 348, 2386, 10.1056/NEJMoa022473 Rueffer, 2001, Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis, J Clin Oncol, 19, 2026, 10.1200/JCO.2001.19.7.2026 Biti, 1994, Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution, Int J Radiat Oncol Biol Phys, 29, 25, 10.1016/0360-3016(94)90222-4 Doria, 1995, Second solid malignancies after combined modality therapy for Hodgkin's disease, J Clin Oncol, 13, 2016, 10.1200/JCO.1995.13.8.2016 Hodgson, 2007, Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma, J Clin Oncol, 25, 1489, 10.1200/JCO.2006.09.0936 Travis, 2003, Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease, JAMA, 290, 465, 10.1001/jama.290.4.465 van Leeuwen, 2003, Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease, J Natl Cancer Inst, 95, 971, 10.1093/jnci/95.13.971 Travis, 2002, Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease, J Natl Cancer Inst, 94, 182, 10.1093/jnci/94.3.182 Girinsky, 2006, Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines, Radiother Oncol, 79, 270, 10.1016/j.radonc.2006.05.015 Swerdlow, 2000, Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment, J Clin Oncol, 18, 498, 10.1200/JCO.2000.18.3.498 Swerdlow, 2001, Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment, J Clin Oncol, 19, 1610, 10.1200/JCO.2001.19.6.1610 van Leeuwen, 2000, Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood, J Clin Oncol, 18, 487, 10.1200/JCO.2000.18.3.487 Aisenberg, 1997, High risk of breast carcinoma after irradiation of young women with Hodgkin's disease, Cancer, 79, 1203, 10.1002/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2 Sankila, 1996, J Clin Oncol, 14, 1442, 10.1200/JCO.1996.14.5.1442 Bhatia, 2003, High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group, J Clin Oncol, 21, 4386, 10.1200/JCO.2003.11.059 Gooley, 1999, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators, Stat Med, 18, 695, 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O Gail, 1989, Projecting individualized probabilities of developing breast cancer for white females who are being examined annually, J Natl Cancer Inst, 81, 1879, 10.1093/jnci/81.24.1879 Travis, 2005, Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma, J Natl Cancer Inst, 97, 1428, 10.1093/jnci/dji290 Mauch, 2005, Report from the Rockefeller Foundation sponsored international workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy, Eur J Haematol, 75, 68, 10.1111/j.1600-0609.2005.00458.x Andre, 2004, Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients, Blood, 103, 1222, 10.1182/blood-2003-04-1124 Mudie, 2006, Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study, J Clin Oncol, 24, 1568, 10.1200/JCO.2005.04.2200 Tward, 2006, The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma, Cancer, 107, 108, 10.1002/cncr.21971 Freedman, 2006, New malignancies following cancer of the uterine corpus and ovary, 231 Curtis, 2005, Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study, Blood, 105, 3802, 10.1182/blood-2004-09-3411 Travis, 1991, Second cancers following non-Hodgkin's lymphoma, Cancer, 67, 2002, 10.1002/1097-0142(19910401)67:7<2002::AID-CNCR2820670729>3.0.CO;2-E Travis, 1992, Hodgkin's disease following non-Hodgkin's lymphoma, Cancer, 69, 2337, 10.1002/1097-0142(19920501)69:9<2337::AID-CNCR2820690923>3.0.CO;2-K Travis, 1993, Acute basophilic leukemia and acute eosinophilic leukemia after therapy for non-Hodgkin's lymphoma, Am J Clin Pathol, 100, 186, 10.1093/ajcp/100.2.186 Travis, 1993, Second cancers among long-term survivors of non-Hodgkin's lymphoma, J Natl Cancer Inst, 85, 1932, 10.1093/jnci/85.23.1932 Travis, 1995, Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma, J Natl Cancer Inst, 87, 524, 10.1093/jnci/87.7.524 Bonnet, 2007, CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte, J Clin Oncol, 25, 787, 10.1200/JCO.2006.07.0722 Shenkier, 2002, Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency, J Clin Oncol, 20, 197, 10.1200/JCO.20.1.197 Schairer, 2007, Comparative mortality for 621 second cancers in 29,356 testicular cancer survivors and 12,420 matched first cancers, J Natl Cancer Inst, 99, 1248, 10.1093/jnci/djm081 van den Belt-Dusebout, 2007, Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer, J Clin Oncol, 25, 4370, 10.1200/JCO.2006.10.5296 Travis, 2005, Second cancers among 40,576 testicular cancer patients: focus on long-term survivors, J Natl Cancer Inst, 97, 1354, 10.1093/jnci/dji278 Fossa, 2005, Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men, J Natl Cancer Inst, 97, 1056, 10.1093/jnci/dji185 Travis, 2000, Treatment-associated leukemia following testicular cancer, J Natl Cancer Inst, 92, 1165, 10.1093/jnci/92.14.1165 Pedersen-Bjergaard, 1991, Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ-cell tumours, Lancet, 338, 359, 10.1016/0140-6736(91)90490-G Kollmannsberger, 1999, Therapy-related malignancies following treatment of germ cell cancer, Int J Cancer, 83, 860, 10.1002/(SICI)1097-0215(19991210)83:6<860::AID-IJC32>3.0.CO;2-L Kirova, 2007, Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review, Int J Radiat Oncol Biol Phys, 68, 359, 10.1016/j.ijrobp.2006.12.011 Gao, 2003, Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study, Int J Radiat Oncol Biol Phys, 56, 1038, 10.1016/S0360-3016(03)00203-7 Hemminki, 2007, Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk, Cancer Res, 67, 868, 10.1158/0008-5472.CAN-06-3854 Boice, 1992, Cancer in the contralateral breast after radiotherapy for breast cancer, N Engl J Med, 326, 781, 10.1056/NEJM199203193261201 Storm, 1992, Adjuvant radiotherapy and risk of contralateral breast cancer, J Natl Cancer Inst, 84, 1245, 10.1093/jnci/84.16.1245 Hill-Kayser, 2006, Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation, Int J Radiat Oncol Biol Phys, 66, 1313, 10.1016/j.ijrobp.2006.07.009 Clarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016/S0140-6736(05)67887-7 2005, Early Breast Cancer Trialists' Collaborative Group (EBDTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet, 365, 1687, 10.1016/S0140-6736(05)66544-0 Fisher, 1994, Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14, J Natl Cancer Inst, 86, 527, 10.1093/jnci/86.7.527 Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371 Magriples, 1993, High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients, J Clin Oncol, 11, 485, 10.1200/JCO.1993.11.3.485 Bergman, 2000, Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen, Lancet, 356, 881, 10.1016/S0140-6736(00)02677-5 Saadat, 2007, Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer: comparison of cohorts treated with and without tamoxifen, Cancer, 110, 31, 10.1002/cncr.22734 Roychoudhuri, 2004, Radiation-induced malignancies following radiotherapy for breast cancer, Br J Cancer, 91, 868, 10.1038/sj.bjc.6602084 Neugut, 1993, Lung cancer after radiation therapy for breast cancer, Cancer, 71, 3054, 10.1002/1097-0142(19930515)71:10<3054::AID-CNCR2820711027>3.0.CO;2-N Zablotska, 2003, Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma, Cancer, 97, 1404, 10.1002/cncr.11214 Deutsch, 2003, The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06, Cancer, 98, 1362, 10.1002/cncr.11655 Neugut, 1994, Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers, Cancer, 73, 1615, 10.1002/1097-0142(19940315)73:6<1615::AID-CNCR2820730612>3.0.CO;2-6 Ford, 2003, Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors, Cancer, 98, 1457, 10.1002/cncr.11669 Huang, 2001, Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma, Cancer, 92, 172, 10.1002/1097-0142(20010701)92:1<172::AID-CNCR1306>3.0.CO;2-K Karlsson, 1998, Soft tissue sarcoma after treatment for breast cancer–a Swedish population-based study, Eur J Cancer, 34, 2068, 10.1016/S0959-8049(98)00319-0 Kirova, 2005, Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review, Cancer, 104, 856, 10.1002/cncr.21223 Rubino, 2003, Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment, Br J Cancer, 89, 840, 10.1038/sj.bjc.6601138 Jessner, 1952, Angiosarcoma in postmastectomy lymphedema (Stewart-Treves syndrome), AMA Arch Derm Syphilol, 65, 123, 10.1001/archderm.1952.01530210002001 Esler-Brauer, 2007, Angiosarcoma developing after conservative treatment for breast carcinoma: case report with review of the current literature, Dermatol Surg, 33, 749, 10.1111/j.1524-4725.2007.33156.x Virtanen, 2007, Angiosarcoma after radiotherapy: a cohort study of 332,163 Finnish cancer patients, Br J Cancer, 97, 115, 10.1038/sj.bjc.6603805 Simonart, 2004, Radiation-induced angiosarcomas, Dermatology, 209, 175, 10.1159/000079885 Curtis, 1992, Risk of leukemia after chemotherapy and radiation treatment for breast cancer, N Engl J Med, 326, 1745, 10.1056/NEJM199206253262605 Praga, 2005, Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide, J Clin Oncol, 23, 4179, 10.1200/JCO.2005.05.029 Campone, 2005, Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group, Ann Oncol, 16, 1343, 10.1093/annonc/mdi251 Park, 2005, Secondary hematological malignancies after breast cancer chemotherapy, Leuk Lymphoma, 46, 1183, 10.1080/10428190500125705 Smith, 2003, Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience, J Clin Oncol, 21, 1195, 10.1200/JCO.2003.03.114 Chen, 2007, Partial breast irradiation. Patient selection, guidelines for treatment, and current results, Front Radiat Ther Oncol, 40, 253, 10.1159/000106040 Liauw, 2006, Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up, Int J Radiat Oncol Biol Phys, 66, 669, 10.1016/j.ijrobp.2006.05.016 Moon, 2006, Cancer incidence after localized therapy for prostate cancer, Cancer, 107, 991, 10.1002/cncr.22083 Kendal, 2006, Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer, Int J Radiat Oncol Biol Phys, 65, 661, 10.1016/j.ijrobp.2005.11.013 Chrouser, 2005, Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer, J Urol, 174, 107, 10.1097/01.ju.0000163459.57305.a1 Hall, 2003, Radiation-induced second cancers: the impact of 3D-CRT and IMRT, Int J Radiat Oncol Biol Phys, 56, 83, 10.1016/S0360-3016(03)00073-7 Pickles, 2002, The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984–2000, Radiother Oncol, 65, 145, 10.1016/S0167-8140(02)00307-9 Brenner, 2000, Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery, Cancer, 88, 398, 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V Neugut, 1997, Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma, Cancer, 79, 1600, 10.1002/(SICI)1097-0142(19970415)79:8<1600::AID-CNCR24>3.0.CO;2-0 Guckenberger, 2007, Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives, Strahlenther Onkol, 183, 57, 10.1007/s00066-007-1631-3 Kry, 2005, The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy, Int J Radiat Oncol Biol Phys, 62, 1195, 10.1016/j.ijrobp.2005.03.053 Kleinerman, 1982, Second cancers following radiotherapy for cervical cancer, J Natl Cancer Inst, 69, 1027 Kleinerman, 1995, Second primary cancer after treatment for cervical cancer. An international cancer registries study, Cancer, 76, 442, 10.1002/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L Boice, 1988, Radiation dose and second cancer risk in patients treated for cancer of the cervix, Radiat Res, 116, 3, 10.2307/3577477 Boice, 1987, Radiation dose and leukemia risk in patients treated for cancer of the cervix, J Natl Cancer Inst, 79, 1295 Chaturvedi, 2007, Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk, J Natl Cancer Inst, 99, 1634, 10.1093/jnci/djm201 Keys, 1999, Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma, N Engl J Med, 340, 1154, 10.1056/NEJM199904153401503 Rose, 1999, Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer, N Engl J Med, 340, 1144, 10.1056/NEJM199904153401502 Morris, 1999, Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer, N Engl J Med, 340, 1137, 10.1056/NEJM199904153401501 Poirier, 1992, Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients, Cancer Res, 52, 149 Greene, 1992, Is cisplatin a human carcinogen?, J Natl Cancer Inst, 84, 306, 10.1093/jnci/84.5.306 Travis, 1999, Risk of leukemia after platinum-based chemotherapy for ovarian cancer, N Engl J Med, 340, 351, 10.1056/NEJM199902043400504 Leon, 2002, Second primary tumors in head and neck cancer patients, Acta Otolaryngol, 122, 765, 10.1080/003655402/000028048 Gallo, 1999, Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?, Int J Cancer, 82, 180, 10.1002/(SICI)1097-0215(19990719)82:2<180::AID-IJC5>3.0.CO;2-P Cianfriglia, 1999, Multiple primary tumours in patients with oral squamous cell carcinoma, Oral Oncol, 35, 157, 10.1016/S1368-8375(98)00105-5 Leon, 1999, Second neoplasm in patients with head and neck cancer, Head Neck, 21, 204, 10.1002/(SICI)1097-0347(199905)21:3<204::AID-HED4>3.0.CO;2-7 Rinaldo, 1996, The association of cancers of the larynx with cancers of the lung, Eur Arch Otorhinolaryngol, 253, 256, 10.1007/BF00171138 Berg, 1970, Incidence of multiple primary cancers. III. Cancers of the respiratory and upper digestive system as multiple primary cancers, J Natl Cancer Inst, 44, 263 Day, 1994, Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol, J Natl Cancer Inst, 86, 131, 10.1093/jnci/86.2.131 Bongers, 1996, The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer, Cancer Epidemiol Biomarkers Prev, 5, 595 Jain, 2004, Prevention of head and neck cancer: current status and future prospects, Curr Probl Cancer, 28, 265, 10.1016/j.currproblcancer.2004.05.003 Smith, 2005, Retinoids as chemoprevention for head and neck cancer: where do we go from here?, Crit Rev Oncol Hematol, 55, 143, 10.1016/j.critrevonc.2005.02.003